RiverGlades Family Offices’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
16,104
+185
+1% +$27.5K 1.17% 20
2026
Q1
$2.33M Buy
+15,919
New +$2.46M 1.37% 16
2025
Q3
$2.25M Sell
16,181
-635
-4% -$85.9K 1.38% 18
2025
Q2
$2.27M Hold
16,816
1.49% 16
2025
Q1
$2.46M Sell
16,816
-500
-3% -$72.6K 1.77% 14
2024
Q4
$2.38M Buy
17,316
+730
+4% +$107K 1.7% 14
2024
Q3
$2.55M Buy
16,586
+615
+4% +$93.2K 1.83% 12
2024
Q2
$2.33M Hold
15,971
1.81% 11
2024
Q1
$2.29M Sell
15,971
-231
-1% -$33.1K 1.82% 13
2023
Q4
$2.34M Sell
16,202
-342
-2% -$44.5K 1.89% 12
2023
Q3
$2.13M Buy
16,544
+323
+2% +$42.9K 1.87% 15
2023
Q2
$2.15M Sell
16,221
-310
-2% -$40.9K 1.92% 12
2023
Q1
$2.14M Sell
16,531
-610
-4% -$79.7K 1.97% 11
2022
Q4
$2.33M Buy
+17,141
New +$2.27M 2.14% 12
2022
Q2
$2.07M Sell
16,161
-347
-2% -$45.5K 1.92% 14
2022
Q1
$2.26M Buy
16,508
+15
+0.1% +$1.99K 1.71% 15
2021
Q4
$2.32M Buy
16,493
+306
+2% +$40.6K 1.68% 13
2021
Q3
$2.06M Sell
16,187
-30
-0.2% -$3.96K 1.61% 15
2021
Q2
$2.04M Sell
16,217
-130
-0.8% -$15.9K 1.58% 15
2021
Q1
$1.91M Sell
16,347
-857
-5% -$98.9K 1.55% 15
2020
Q4
$1.95M Sell
17,204
-26
-0.2% -$2.84K 1.66% 14
2020
Q3
$1.82M Buy
17,230
+75
+0.4% +$7.89K 1.74% 15
2020
Q2
$1.72M Buy
17,155
+515
+3% +$50.8K 1.76% 15
2020
Q1
$1.47M Buy
16,640
+265
+2% +$25.7K 1.57% 17
2019
Q4
$1.67M Sell
16,375
-210
-1% -$20.2K 1.44% 21
2019
Q3
$1.5M Sell
16,585
-585
-3% -$53.4K 1.34% 22
2019
Q2
$1.59M Sell
17,170
-385
-2% -$34.6K 1.42% 21
2019
Q1
$1.61M Buy
+17,555
New +$1.58M 1.46% 21
2018
Q4
Sell
-17,925
Closed -$1.71M 86
2018
Q3
$1.71M Sell
17,925
-795
-4% -$71.8K 1.45% 19
2018
Q2
$1.56M Sell
18,720
-650
-3% -$53.9K 1.36% 20
2018
Q1
$1.58M Sell
19,370
-1,105
-5% -$94.1K 1.26% 20
2017
Q4
$1.69M Buy
+20,475
New +$1.69M 1.39% 19

Other funds holding XLV

RiverGlades Family Offices's XLV Position: Q2 2026 in Review

RiverGlades Family Offices increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 1.2% in Q2 2026, buying an estimated $27.5K and bringing the position to 16,104 shares worth $2.56M. The position accounts for 1.17% of the portfolio, ranked #20.

RiverGlades Family Offices first reported a position in XLV in Q4 2017 and has held it in 32 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • RiverGlades Family Offices held 16,104 shares of State Street Health Care Select Sector SPDR ETF worth $2.56M as of Q2 2026.
  • RiverGlades Family Offices bought 185 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $27.5K.
  • State Street Health Care Select Sector SPDR ETF made up 1.17% of RiverGlades Family Offices's portfolio in Q2 2026, its #20 holding.
  • RiverGlades Family Offices first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2017 and has held it in 32 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on RiverGlades Family Offices's 13F filing for Q2 2026, filed 10 Aug 2026.